Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Pharmagel International
WARNING LETTER
•Pharmagel International•March 31, 2015

Pharmagel International – FDA Warning Letter, Mar 31, 2015

Record Details

The FDA issued a Warning Letter to Pharmagel International after reviewing their website, http://www.pharmagel.net/, in March 2015. The FDA determined that five products—Beta-C, Bio-A Concentrate, Eye Firm, Pharma Clear Medicated Moisturizer, and Slender Shaper—are promoted with claims that cause them to be unapproved new drugs and/or misbranded drugs under the Federal Food, Drug, and Cosmetic Act (the Act).

The products are deemed drugs because their website claims indicate they are intended for the cure, mitigation, treatment, or prevention of disease, and/or to affect the structure or function of the human body. Examples of drug claims include "helps erase and repair the ravages of sun damage," "stimulates collagen production," "speeds healing," "helps control acne by reducing inflammation and bacteria production," "reduces that red inflamed appearance associated with Rosacea and acne," "increases fat metabolism," and "cellulite starts to disappear."

Since these products are not generally recognized as safe and effective for their claimed uses, they are considered "new drugs" under section 201(p) of the Act and require an approved New Drug Application (NDA) before interstate commerce introduction, which they lack, violating section 301(d).

Furthermore, "Bio-A Concentrate" and "Pharma Clear Medicated Moisturizer" are misbranded under section 502(f)(1

Company
Pharmagel International
Inspection date
March 31, 2015
Product type
Food
Office
Center for Food Safety and Applied Nutrition
Person
  • William A. Correll (Director)
View Company Profile

ID · 0a6daa2b-cc80-41d0-986d-10928cd9920b

Violation Codes8
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmagel International
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.